Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic" ALT"Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic"June 1, 2017By Alex Keown,…

Continue ReadingBicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic

Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-personnel-leaving.jpg" NAME"Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data" ALT"Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data"May 31, 2017By Alex Keown,…

Continue ReadingAkari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data

Spectacular Data Posted for Novartis AG's Next Generation CAR-T Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-novartis.jpg" NAME"Spectacular Data Posted for Novartis AG's Next Generation CAR-T Drug" ALT"Spectacular Data Posted for Novartis AG's Next Generation CAR-T Drug"May 31, 2017By Mark Terry, BioSpace.com Breaking News Staff...…

Continue ReadingSpectacular Data Posted for Novartis AG's Next Generation CAR-T Drug